Borner C, Eppenberger U, Wyss R, Fabbro D
Department of Research, University Clinic Medical School, Basel, Switzerland.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2110-4. doi: 10.1073/pnas.85.7.2110.
The phorbol 12-myristate 13-acetate (PMA)-dependent down-regulation of immunoprecipitable protein kinase C was studied in human breast cancer cell lines that display different growth inhibitions toward the tumor promoter. PMA induces translocation of [35S]methionine-prelabeled cytosolic protein kinase C to membranes, followed by complete degradation of the enzyme (t1/2, 2 hr). PMA does not affect the protein kinase C synthesis; 20-80% of total protein kinase C of control cells was still immunoprecipitable as membrane-bound 74- and 80-kDa protein kinase C-related polypeptides if cells were allowed to incorporate [35S]methionine during PMA exposure for greater than 6 hr. These two proteins lack protein kinase activity and phorbol ester binding but reveal V8 peptide patterns identical to the active forms of protein kinase C (77/80 kDa) of PMA-untreated cells. The amounts of the immunoprecipitable membrane-bound 80-kDa protein kinase C-related polypeptide synthesized during the prolonged PMA treatment appear to inversely correlate with the extent of PMA-mediated growth inhibition of the respective human breast cancer cell line. These data suggest that after homologous down-regulation, functional protein kinase C (77/80 kDa) is replaced by a population of membrane-associated but enzymatically inactive protein kinase C-related polypeptides (74/80 kDa).
在对肿瘤启动子表现出不同生长抑制作用的人乳腺癌细胞系中,研究了佛波醇12 -肉豆蔻酸酯13 -乙酸酯(PMA)依赖性的免疫沉淀蛋白激酶C的下调情况。PMA诱导[35S]甲硫氨酸预标记的胞质蛋白激酶C转位至细胞膜,随后该酶完全降解(半衰期为2小时)。PMA不影响蛋白激酶C的合成;如果在PMA暴露期间让细胞掺入[35S]甲硫氨酸超过6小时,对照细胞中20 - 80%的总蛋白激酶C仍可作为与膜结合的74 kDa和80 kDa蛋白激酶C相关多肽进行免疫沉淀。这两种蛋白缺乏蛋白激酶活性和佛波醇酯结合能力,但显示出与未用PMA处理细胞的活性形式蛋白激酶C(77/80 kDa)相同的V8肽图谱。在延长的PMA处理期间合成的可免疫沉淀的与膜结合的80 kDa蛋白激酶C相关多肽的量,似乎与相应人乳腺癌细胞系中PMA介导的生长抑制程度呈负相关。这些数据表明,在同源下调后,功能性蛋白激酶C(77/80 kDa)被一群与膜相关但无酶活性的蛋白激酶C相关多肽(74/80 kDa)所取代。